Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Harvard Bioscience, Inc. - Common Stock (NQ:HBIO)

7.880 -0.320 (-3.90%)
Streaming Delayed Price Updated: 1:10 PM EDT, Sep 3, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 10,243
Open 8.370
Bid (Size) 7.860 (100)
Ask (Size) 8.010 (200)
Prev. Close 8.200
Today's Range 7.850 - 8.370
52wk Range 3.755 - 9.400
Shares Outstanding 42,688,246
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Harvard Bioscience (HBIO) Q2 2026 Earnings Call Transcript ↗
CRO demand drove 11% revenue growth, though margin pressures from China sales tempered gains. 
Via The Motley Fool
Topics Earnings
News headline image
Harvard Bioscience Announces Second Quarter 2026 Financial Results
From Harvard Bioscience, Inc.
Via GlobeNewswire

Performance

YTD
+20.9%
+20.9%
1 Month
+24.9%
+24.9%
3 Month
+21.2%
+21.2%
6 Month
+37.4%
+37.4%
1 Year
+61.1%
+61.1%

More News

Read More
News headline image
Harvard Bioscience Schedules Second Quarter 2026 Earnings Conference Call for August 11, 2026 at 8:00 AM ET
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Sidoti Events, LLC's May Micro-Cap Virtual Conference
Via ACCESS Newswire
Harvard Bioscience Inc (NASDAQ:HBIO) Q1 Results Show Revenue Miss Offsets Earnings Beat ↗
Via Chartmill
Harvard Bioscience Inc. (NASDAQ:HBIO) Reports Mixed Q4 2025 Results and Cautious 2026 Outlook ↗
Via Chartmill
News headline image
HBIO Q1 2026 Earnings Transcript ↗
Via The Motley Fool
News headline image
Harvard Bioscience Announces First Quarter 2026 Financial Results
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience to Participate in Upcoming Investor Conferences
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Schedules First Quarter 2026 Earnings Conference Call for May 12, 2026 at 8:00 AM ET
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Earnings Scheduled For November 6, 2025 ↗
Via Benzinga
News headline image
Harvard Bioscience (HBIO) Earnings Transcript ↗
Via The Motley Fool
Topics World Trade
News headline image
Harvard Bioscience Announces Fourth Quarter and Full-Year 2025 Financial Results
From Harvard Bioscience, Inc.
Via GlobeNewswire
Stay updated with the stocks that are on the move in today's after-hours session. ↗
Via Chartmill
News headline image
Harvard Bioscience Announces Reverse Stock Split
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience to Participate in KeyBanc’s Virtual Healthcare Forum
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Schedules Fourth Quarter 2025 Earnings Conference Call for March 12, 2026 at 8:00 AM ET
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Announces Preliminary Fourth Quarter Financial Results, Positive Outlook for 2026 & Outlines Long-Term Strategic Focus Areas
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Announces Strategic Consolidation of Manufacturing Operations to Improve Efficiency and Support Long-Term Growth
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Announces the Successful Completion of Debt Refinancing with Comprehensive Growth Financing Package
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
Harvard Bioscience Inc (NASDAQ:HBIO) Reports Mixed Q3 2025 Results Amid Restructuring Efforts ↗
Via Chartmill
News headline image
Harvard Bioscience Announces Third Quarter 2025 Financial Results
From Harvard Bioscience, Inc.
Via GlobeNewswire
News headline image
These stocks have an unusual volume in today's session ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
Via Benzinga
News headline image
These stocks are moving in today's session ↗
Via Chartmill

Frequently Asked Questions

Is Harvard Bioscience, Inc. - Common Stock publicly traded?
Yes, Harvard Bioscience, Inc. - Common Stock is publicly traded.
What exchange does Harvard Bioscience, Inc. - Common Stock trade on?
Harvard Bioscience, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Harvard Bioscience, Inc. - Common Stock?
The ticker symbol for Harvard Bioscience, Inc. - Common Stock is HBIO on the Nasdaq Stock Market
What is the current price of Harvard Bioscience, Inc. - Common Stock?
The current price of Harvard Bioscience, Inc. - Common Stock is 7.880
When was Harvard Bioscience, Inc. - Common Stock last traded?
The last trade of Harvard Bioscience, Inc. - Common Stock was at 09/03/26 01:10 PM ET
What is the market capitalization of Harvard Bioscience, Inc. - Common Stock?
The market capitalization of Harvard Bioscience, Inc. - Common Stock is 336.38M
How many shares of Harvard Bioscience, Inc. - Common Stock are outstanding?
Harvard Bioscience, Inc. - Common Stock has 336M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.